Aurinia Pharmaceuticals
AUPH
AUPH
68 hedge funds and large institutions have $108M invested in Aurinia Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 17 increasing their positions, 15 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
27% less capital invested
Capital invested by funds: $147M → $108M (-$39M)
71% less call options, than puts
Call options by funds: $865K | Put options by funds: $2.99M
Holders
68
Holding in Top 10
–
Calls
$865K
Puts
$2.99M
Top Buyers
| 1 | +$3.26M | |
| 2 | +$3.09M | |
| 3 | +$2.43M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$1.88M |
| 5 |
Goldman Sachs
New York
|
+$1.45M |
Top Sellers
| 1 | -$4.69M | |
| 2 | -$2.86M | |
| 3 | -$2.08M | |
| 4 |
SC
Sculptor Capital
New York
|
-$1.16M |
| 5 |
Morgan Stanley
New York
|
-$921K |